The "Neuro-Metabolic" Bridge: How 2026 is Redefining "Success" in PKU Care.
In late 2026, the industry is pivoting toward "Executive Function Outcomes." This year, a radical new class of Large Neutral Amino Acid (LNAA) supplements has been optimized to block Phe from crossing the blood-brain barrier more effectively. This innovation is a primary driver for the market, as it shifts the goal of treatment from "Lowering Blood Phe" to "Optimizing Brain Phe." Using these...
0 Комментарии 0 Поделились 152 Просмотры 0 предпросмотр
Спонсоры